Intizol Vaginal (Metronidazole)

Metronidazole enters anaerobic bacteria and protozoa and is reduced to reactive nitro radicals. These radicals damage the organism’s DNA and inhibit nucleic acid synthesis, leading to cell death. Aerobic cells lack the necessary reduction pathways, so the drug selectively targets the anaerobic pathogens responsible for vaginal infections.

The dosage and duration of Intizol Vaginal are determined by the prescribing healthcare professional based on the specific infection, severity, and patient factors. Patients should follow the prescriber’s instructions precisely and not alter the regimen without medical advice.

Intizol Vaginal is classified as Pregnancy Category B, indicating that animal studies have not shown risk and there are no well‑controlled studies in pregnant women. It is generally considered safe when clearly needed. Small amounts may be excreted in breast milk, so breastfeeding women should discuss use with their clinician.

To order Intizol Vaginal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

The main alternatives for bacterial vaginosis and trichomoniasis include clindamycin and tinidazole. Metronidazole, the active ingredient in Intizol Vaginal, has a broad spectrum against anaerobic bacteria and protozoa, a well‑established safety profile, and is often preferred for its efficacy and lower cost. Clindamycin may be used when metronidazole intolerance occurs, while tinidazole offers a longer half‑life but can be more expensive.

Intizol Vaginal should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability.

Intizol Vaginal is applied intravaginally as directed by a healthcare professional. The medication is typically inserted into the vagina using the supplied applicator or a clean fingertip, following the prescribed schedule. Patients should wash their hands before and after administration and avoid sexual intercourse or tampon use for the period recommended by the prescriber.

Serious risks include severe allergic reactions such as rash, swelling, or breathing difficulties, and rare but life‑threatening conditions like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Liver toxicity and neurologic effects such as seizures may also occur. Patients should seek immediate medical attention if they experience any of these symptoms.

Intizol Vaginal should not be used by individuals with a known hypersensitivity to metronidazole or any nitroimidazole compounds. It is also contraindicated in patients with severe liver disease or those who are currently consuming alcohol, due to the risk of a disulfiram‑like reaction. Pregnant or breastfeeding women should only use it when clearly indicated by a healthcare provider.